Berliner Boersenzeitung - First Covid vaccine side-effect claims land in German courts

EUR -
AED 4.273929
AFN 79.563008
ALL 96.99956
AMD 446.699302
ANG 2.082887
AOA 1067.172475
ARS 1513.495974
AUD 1.811984
AWG 2.095068
AZN 1.980282
BAM 1.953014
BBD 2.342988
BDT 141.538113
BGN 1.953548
BHD 0.438761
BIF 3470.03368
BMD 1.163765
BND 1.497287
BOB 8.039189
BRL 6.393747
BSD 1.163286
BTN 101.457565
BWP 15.652951
BYN 3.917732
BYR 22809.794581
BZD 2.333961
CAD 1.616231
CDF 3343.496888
CHF 0.93904
CLF 0.028631
CLP 1123.196525
CNY 8.351411
CNH 8.357165
COP 4682.6879
CRC 587.010619
CUC 1.163765
CUP 30.839773
CVE 110.109834
CZK 24.527105
DJF 207.16142
DKK 7.464471
DOP 72.226667
DZD 151.212643
EGP 56.475771
ERN 17.456475
ETB 164.46973
FJD 2.645005
FKP 0.865247
GBP 0.865015
GEL 3.136416
GGP 0.865247
GHS 12.796792
GIP 0.865247
GMD 83.791319
GNF 10084.788579
GTQ 8.920238
GYD 243.392698
HKD 9.093224
HNL 30.430594
HRK 7.530958
HTG 152.212234
HUF 395.625373
IDR 18989.153988
ILS 3.979477
IMP 0.865247
INR 101.556595
IQD 1523.620194
IRR 48936.319813
ISK 143.399073
JEP 0.865247
JMD 186.953334
JOD 0.825084
JPY 172.080701
KES 150.300222
KGS 101.76892
KHR 4663.728462
KMF 491.70293
KPW 1047.397848
KRW 1627.932877
KWD 0.355798
KYD 0.969496
KZT 625.32909
LAK 25217.089376
LBP 104686.123573
LKR 351.187741
LRD 233.256329
LSL 20.592139
LTL 3.436295
LVL 0.70395
LYD 6.311997
MAD 10.494032
MDL 19.585662
MGA 5128.103994
MKD 61.4534
MMK 2442.664639
MNT 4184.984793
MOP 9.36261
MRU 46.438559
MUR 53.311782
MVR 17.921883
MWK 2017.287258
MXN 21.839212
MYR 4.916326
MZN 74.375976
NAD 20.592493
NGN 1787.007942
NIO 42.808938
NOK 11.851085
NPR 162.331705
NZD 1.998999
OMR 0.447468
PAB 1.163336
PEN 4.05941
PGK 4.916987
PHP 66.442257
PKR 330.074533
PLN 4.252011
PYG 8406.118035
QAR 4.239907
RON 5.054459
RSD 117.181879
RUB 93.77162
RWF 1683.935532
SAR 4.367349
SBD 9.566582
SCR 17.172541
SDG 698.842715
SEK 11.16307
SGD 1.49826
SHP 0.914537
SLE 27.112333
SLL 24403.568427
SOS 664.905869
SRD 44.012444
STD 24087.586481
STN 24.466888
SVC 10.178656
SYP 15131.221706
SZL 20.599299
THB 37.996961
TJS 10.935594
TMT 4.073178
TND 3.405343
TOP 2.725656
TRY 47.644305
TTD 7.883399
TWD 35.514597
TZS 2898.804816
UAH 47.924765
UGX 4147.155854
USD 1.163765
UYU 46.774086
UZS 14501.564486
VES 160.549411
VND 30761.219146
VUV 139.547262
WST 3.150773
XAF 655.076088
XAG 0.030753
XAU 0.000348
XCD 3.145133
XCG 2.09668
XDR 0.814104
XOF 655.03393
XPF 119.331742
YER 279.537305
ZAR 20.602767
ZMK 10475.282277
ZMW 26.902822
ZWL 374.731865
  • RBGPF

    0.0000

    73.27

    0%

  • CMSC

    0.0500

    23.44

    +0.21%

  • RYCEF

    -0.7200

    13.82

    -5.21%

  • AZN

    0.9800

    80.52

    +1.22%

  • GSK

    0.4500

    40.07

    +1.12%

  • VOD

    0.1830

    11.9

    +1.54%

  • BP

    0.0600

    33.88

    +0.18%

  • BTI

    1.5400

    59.01

    +2.61%

  • NGG

    1.1000

    72.08

    +1.53%

  • RIO

    0.0300

    60.62

    +0.05%

  • RELX

    0.9000

    48.69

    +1.85%

  • CMSD

    0.1000

    23.69

    +0.42%

  • BCC

    -3.5600

    84.5

    -4.21%

  • JRI

    0.0500

    13.33

    +0.38%

  • SCS

    -0.0600

    16.18

    -0.37%

  • BCE

    0.1600

    25.74

    +0.62%

First Covid vaccine side-effect claims land in German courts

First Covid vaccine side-effect claims land in German courts

Vaccine-maker BioNTech faced Monday its first legal claim in its home country of Germany over adverse effects allegedly suffered by some users of its Covid vaccines, more than two years after one of the world's fastest and most extensive inoculation campaigns.

Text size:

In the face of the deadly pandemic that emerged in early 2020, which prompted border closures and lockdowns that trapped millions of people in their homes, the arrival of Covid vaccines had been widely hailed as a life-saver.

But the jabs, which had been developed at breakneck speed and granted early approval for usage, are now the focus of legal procedures in several countries including France and Britain where plaintiffs argue that the vaccines harmed their health.

In Germany, a court in Hamburg was prepared to hear a case from Monday against BioNTech, which, together with US giant Pfizer, produced the first mRNA vaccine Comirnaty.

The hearing was delayed however after the claimant's lawyers put in a last-minute challenge of the judge's impartiality, and asking instead for a panel of judges to rule on the case.

In her claim, the plaintiff reported suffering effects including "pain in the upper body, swelling of the extremities, exhaustion, fatigue and sleeping disorders" after receiving the vaccine, the court said.

She is seeking 150,000 euros ($162,000) in damages and recognition that the "defendant is bound to provide material damages", the court added.

Her lawyer Thomas Ulbrich, who is also representing another 250 people in similar cases, said his clients were "all healthy" before suffering from symptoms, allegedly following their jabs.

He believes that the medical files he has on hand offer a link between the vaccines and the symptoms experienced by his clients.

- 'Rocky and long road' -

BioNTech's mRNA vaccine, a scientific breakthrough, had been granted conditional marketing authorisation as early as December 21, 2020, by the EU regulatory authority EMA.

Similar authorisation for Moderna, another mRNA vaccine maker, swiftly followed.

With fears of catching the disease running high, the vaccines were pre-ordered by governments even during their development phases, and deployment swiftly followed once regulatory authorities gave their approval.

But the new generation of inoculations also sparked a wave of vaccine sceptics questioning the safety of the jabs.

Out of 192 million jabs given in Germany, the country's medicines regulator, the Paul Ehrlich Institute, said 338,857 suspected cases of side effects were reported, including 54,879 severe reactions.

Among the worst cases, "the symptoms are very different, they vary from stroke to thrombosis to cardiac diseases", said another German lawyer, Joachim Caesar-Preller, who represents 140 clients making similar claims.

He is seeking up to one million euros in damages per case -- plus interest -- but concedes that a "rocky and long road" lies ahead in the legal battles.

- 'Not an isolated case' -

A key point for the courts is whether the side effects of the medication, when used correctly, surpass "a justifiable level according to the findings of medical science".

In other words, the effects have to be sufficiently serious to be taken into account, said Anatol Dutta, a professor at Munich University.

A claimant identified only as Kathrin K., 45, believes her symptoms are severe enough.

She said she lost a lot of weight after taking the vaccine and had to undergo several intestinal operations.

"I hate it when people tell me that I'm an isolated case," she said. "I'm not."

To address the question of causality, the courts would likely have to obtain expert advice.

Besides the legal avenue, claimants can also turn to the state for compensation for the loss of income.

More than 8,000 such applications had been made as of April, and so far about five percent have been successful, according to German media.

BioNTech told AFP that the number of liability claims made to the company is very small when compared to the number of doses it has delivered worldwide, and that each claim had to be examined individually.

"Justified liability claims would of course be met by BioNTech," it said, adding however that "no causal relationship between (the) health impairments presented and vaccination with Comirnaty has been proven" in the cases it had reviewed so far.

Another lawyer, Anja Dornhoff, advises her clients to establish a chronology and to get medical practitioners to document the development of their symptoms.

"I hope that people with post-vaccination syndromes can be taken seriously," she said.

(H.Schneide--BBZ)